Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01863381 · ClinicalTrials.gov registry record · NA
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
A NA study, sponsored by LifeBridge Health.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01863381: Clinical Trial NA study, sponsored by LifeBridge Health.
NCT01863381 is a NA study that was terminated before completion, run by LifeBridge Health. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01863381, a NA study, was terminated before completion, sponsored by LifeBridge Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research is being done to determine the accuracy of two noninvasive methods of measuring the pressure of the cerebrospinal fluid (CSF), also known as intracranial pressure or ICP.
Primary Outcome
Bland-Altman analysis: the difference between the noninvasive ICP and the invasive ICP is plotted against the mean of both the noninvasive and invasive ICP at each ICP level
Interventions
- DEVICE Tympanic membrane displacement (TMD)
- DEVICE DPOAE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
| Phase | NA |
Why NCT01863381 stopped before completion
NCT01863381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Tympanic membrane displacement (TMD) is the first listed.
NCT01863381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01863381 about?
NCT01863381 is a clinical study titled "Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement". This research is being done to determine the accuracy of two noninvasive methods of measuring the pressure of the cerebrospinal fluid (CSF), also known as intracranial pressure or ICP.
What is the current status of trial NCT01863381?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01863381?
The interventions under investigation include: Tympanic membrane displacement (TMD) (DEVICE), DPOAE (DEVICE).
Who is sponsoring clinical trial NCT01863381?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01863381's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia